IMUN

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/25/2016
Contact Info
  • 37 North Orange Avenue
  • Suite 607
  • Orlando, FL 32801

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001559356
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: FL, USA
Year of Inc. 1998
Employees 6 a/o Dec 11, 2015
Company Officers/Contacts
Noreen Griffin CEO
Christopher Pearce COO
Peter Aronstam CFO
Dr. Fengping Shan Chief Scientific Officer
Kirsten Bartholomew General Counsel, Secretary
Company Directors
Nicholas Plotnikoff Non-Executive Chairman
Paul Akin
Noreen Griffin
Christopher Pearce
Clifford A. Selsky
Edward Teraskiewicz
Company Notes
  • Formerly=TNI BioTech, Inc. until 12-2014
  • Formerly=pH Environmental Inc until 5-2012
  • Formerly=Resort Clubs International, Inc. until 2-2012
  • Formerly=Galliano International Ltd. until 11-04
  • Note=11-10-04 company is in the development stage
Service Providers
Accounting/Auditing Firm
Turner, Stone & Company, L.L.P.
12700 Park Central Drive
Suite 1400
Dallas, TX, 75251
United States

Legal Counsel
Austin Legal Group
3990 Old Town Ave
Suite A-112
San Diego, CA, 92110
United States

Investor Relations Firm
Not Available
IMUN Security Details
Share Structure
Market Value1 $15,142,847 a/o Dec 02, 2016
Authorized Shares 500,000,000 a/o Sep 30, 2016
Outstanding Shares 241,128,131 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,986,000 a/o Dec 11, 2015
Par Value Not Available
Transfer Agent(s)
ClearTrust, LLC
Shareholders
Shareholders of Record 732 a/o Mar 30, 2016
Short Selling Data
Short Interest 16,184 (1,122.36%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security